Lantheus Holdings Aktie [WKN DE: A117UE / ISIN: US5165441032]

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (groß)	News + Adhoc	Bilanz/GuV	Termine	Zertifikate	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil	Optionsscheine	Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV	Knock-Outs
Historisch	Analysen

Kurse + Charts + Realtime
Kurs + Chart
Times + Sales
Börsenplätze
Historisch

News + Analysen
News + Adhoc
Analysen
Kursziele

Fundamental
Bilanz/GuV
Schätzungen
Dividende/GV
Analysen

Unternehmen
Termine
Profil

zugeh. Wertpapiere
Zertifikate
Optionsscheine
Knock-Outs

Nachrichten zu Lantheus Holdings Inc

03.09.20		Lantheus Holdings to Present at the Wells Fargo 2020 Virtual Healthcare Conference (Businesswire)
12.08.20		Lantheus Holdings, Inc. Announces FDA Approval of VIALMIX® RFID Device for DEFINITY® (Businesswire)
30.07.20		Lantheus Holdings, Inc. Reports Second Quarter 2020 Financial Results (Businesswire)
23.07.20		Lantheus Holdings to Host Second Quarter 2020 Earnings Conference Call on July 30, 2020 at 8:00 a.m. Eastern Time (Businesswire)
01.07.20		Lantheus Holdings to Showcase the Potential of PyL™ Imaging Agent at the Virtual Society of Nuclear Medicine and Molecular Imaging (SNMMI) 2020 Annual Meeting (Businesswire)
22.06.20		Lantheus Completes Merger with Progenics (Businesswire)
16.06.20		Lantheus Stockholders Approve Share Issuance For Merger with Progenics (Businesswire)
16.06.20		Lantheus Holdings to Present at the BMO 2020 Prescriptions for Success Virtual Healthcare Conference (Businesswire)
20.05.20		Lantheus Holdings to Present at the Jefferies Virtual Healthcare Conference (Businesswire)
30.04.20		Lantheus Holdings, Inc. Reports First Quarter 2020 Financial Results (Businesswire)
16.04.20		Lantheus Holdings to Host First Quarter 2020 Earnings Conference Call on April 30, 2020 at 8:00 a.m. Eastern Time (Businesswire)
14.04.20		Velan Capital Agrees to Support Merger of Lantheus and Progenics (Businesswire)
09.04.20		Lantheus Holdings, Inc. Reports Preliminary Q1 Revenue Near Top End of Previously Disclosed Guidance Range; Withdraws 2020 Financial Guidance (Businesswire)
06.04.20		Lantheus Holdings, Inc. to Hold 2020 Annual Meeting of Stockholders Virtually (Businesswire)
02.04.20		Lantheus and Progenics Reschedule Their Respective Special Meetings of Stockholders for Proposed Merger (Businesswire)
25.02.20		Lantheus Holdings, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results (Businesswire)
20.02.20		Lantheus and Progenics Agree to Amended Transaction Terms (Businesswire)
18.02.20		Lantheus Holdings to Present at the 9th Annual SVB Leerink Global Healthcare Conference (Businesswire)
18.02.20		Lantheus Holdings to Host Fourth Quarter and Full Year 2019 Earnings Conference Call on February 25, 2020 at 8:00 a.m. Eastern Time (Businesswire)
03.02.20		Lantheus Announces Topline Results for BENEFIT 1 LVEF Clinical Trial (Businesswire)
27.01.20		Lantheus Holdings Announces Senior Leadership Appointment (Businesswire)
13.01.20		Lantheus Holdings Announces Senior Leadership Appointment (Businesswire)
09.12.19		Lantheus Enters into Strategic Collaboration with CarThera for Use of Microbubbles in Combination with SonoCloud® System for Treatment of Glioblastoma (Businesswire)
21.11.19		Lantheus Holdings to Present at the 31st Annual Piper Jaffray Healthcare Conference (Businesswire)
31.10.19		Lantheus Holdings, Inc. Reports Third Quarter 2019 Financial Results (Businesswire)
29.10.19		Lantheus Holdings to Present at the Credit Suisse 28th Annual Healthcare Conference (Businesswire)
17.10.19		Lantheus Holdings to Host Third Quarter 2019 Earnings Conference Call on October 31, 2019 at 8:00 a.m. Eastern Time (Businesswire)
02.10.19		Lantheus To Acquire Progenics In All-Stock Deal - Quick Facts (RTTNews)
02.10.19		Lantheus to Acquire Progenics to Form a Leading Precision Diagnostics Imaging and Therapeutics Company (Businesswire)
22.08.19		Lantheus Holdings to Present at the Wells Fargo Securities 2019 Healthcare Conference (Businesswire)
25.07.19		Lantheus Holdings, Inc. Reports Second Quarter 2019 Financial Results (Businesswire)
11.07.19		Lantheus Holdings to Host Second Quarter 2019 Earnings Conference Call on July 25, 2019 at 8:00 a.m. Eastern Time (Businesswire)
24.06.19		Lantheus Announces Presentation of New Patient Outcomes Data for DEFINITY® at the American Society of Echocardiography 2019 Annual Scientific Sessions (Businesswire)
20.06.19		Lantheus Announces New Patient Outcomes Data for DEFINITY® to be Presented at the American Society of Echocardiography 2019 Annual Scientific Sessions (Businesswire)
30.05.19		Lantheus Announces Strategic Collaboration with NanoMab to Provide a Novel Biomarker for Clinical Development and Management of Immuno-Oncology Therapies (Businesswire)
22.05.19		Lantheus Holdings, Inc. to Present at the Jefferies 2019 Global Healthcare Conference (Businesswire)
07.05.19		Lantheus Holdings, Inc. to Present at the 2019 UBS Global Healthcare Conference (Businesswire)
30.04.19		Lantheus Holdings, Inc. Reports First Quarter 2019 Financial Results (Businesswire)
16.04.19		Lantheus Holdings to Host First Quarter 2019 Earnings Conference Call on April 30, 2019 at 8:00 a.m. Eastern Time (Businesswire)
02.04.19		Lantheus Enters Strategic Collaboration with Cerevast for Potential New Eye Care Application Using Microbubbles (Businesswire)
25.03.19		Lantheus Announces Upcoming Retirement of Chief Medical Officer in September 2019 and Promotion of Senior Vice President, Technical Operations to Chief Operations Officer (Businesswire)
05.03.19		Lantheus Holdings - Creating A Strong Image (RTTNews)
21.02.19		8 Top Gainers In Healthcare Sector (LMAT, CLSD, LNTH...) (RTTNews)
19.02.19		Lantheus Holdings, Inc. Reports Fourth Quarter and Full Year 2018 Financial Results (Businesswire)
05.02.19		Lantheus Holdings Announces Earnings Release and Conference Call Dates for the Fourth Quarter and Full Year 2018 (Businesswire)
28.11.18		Lantheus Holdings to Present at the BMO Prescriptions for Success Healthcare Conference (Businesswire)
01.11.18		Lantheus Holdings to Present at Upcoming Investor Conferences (Businesswire)
30.10.18		Lantheus Holdings, Inc. Reports Third Quarter 2018 Financial Results (Businesswire)
16.10.18		Lantheus Holdings to Host Third Quarter 2018 Earnings Conference Call on October 30, 2018 at 4:30 p.m. Eastern Time (Businesswire)
19.09.18		Lantheus Holdings to Present at the 2018 Cantor Fitzgerald Global Healthcare Conference (Businesswire)

Zurück | 1 | 2 | Weiter

Newssuche

Meistgelesene Nachrichten

Bitcoin als Chance: MicroStrategy-Chef fordert Microsoft zu mutigem Schritt auf

CompuGroup-Aktie mit zweistelligem Plus: CVC bestätigt Akquisition

Bayer-Aktie erholt sich weiter: Glyphosat-Fehlprozess in USA

Neue Kooperationsvereinbarung: Palantir-Aktie erreicht neues Rekordhoch - und sackt dann ab

Generative KI: Warum der NVIDIA-CEO auf Accenture setzt

voestalpine-Aktie gewinnt: Wiener Privatbank senkt Kursziel

finanzen.net Apps

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.

JETZT MEHR ERFAHREN

Aktien ATX DAX EuroStoxx 50 Dow Jones NASDAQ 100 Nikkei 225 S&P 500

Kontakt - Impressum - Werbung

Sitemap - Datenschutz - Disclaimer - AGB - Privatsphäre-Einstellungen

Für die aufgeführten Inhalte kann keine Gewährleistung für die Vollständigkeit, Richtigkeit und Genauigkeit übernommen werden.
Kursinformationen von SIX Financial Information Deutschland GmbH. Verzögerung 15 Min. (Nasdaq, NYSE: 20 Min.).
© 1999-2024 finanzen.net GmbH

*Werbehinweise: Die Billigung des Basisprospekts durch die Bundesanstalt für Finanzdienstleistungsaufsicht ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.

⁵Hinweis zu Plus500: 82% der Kleinanlegerkonten verlieren Geld beim CFD-Handel mit diesem Anbieter. Sie sollten überlegen, ob Sie es sich leisten können, das hohe Risiko einzugehen, Ihr Geld zu verlieren. Plus500UK Ltd ist zugelassen und reguliert durch Financial Conduct Authority (FRN 509909). Plus500CY Ltd authorized & regulated by CySEC (#250/14).

Währungsrechner News Devisen Dollarkurs Aktienkurse Bitcoin Rohstoffe Fonds

Portfolioname: Watchlistname:
Portfolio:
Name:
Typ:
ISIN:
Börse:
Anzahl:
Aktueller Kurs:
Kurszeit:
Kaufpreis:
Kaufdatum:	12.12.2024 00:57
Kaufwert:	EUR
	Hinzufügen Speichern